Measured by its ability to inhibit papain cleavage of a fluorogenic peptide substrate Z-FR-AMC (Catalog # ES009). The IC50 value is <15 nM, as measured under the described conditions.
Source
E. coli-derived human Cystatin B protein Met2-Phe98, with an N-terminal Met and 7-His tag
>95%, by SDS-PAGE under reducing conditions and visualized by silver stain
Endotoxin Note
<1.0 EU per 1 μg of the protein by the LAL method.
Applications/Dilutions
Dilutions
Inhibition Activity
Theoretical MW
12 kDa. Disclaimer note: The observed molecular weight of the protein may vary from the listed predicted molecular weight due to post translational modifications, post translation cleavages, relative charges, and other experimental factors.
SDS-PAGE
13 kDa, reducing conditions
Publications
Read Publications using 1408-PI in the following applications:
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
6 months from date of receipt, -20 to -70 °C as supplied.
3 months, -20 to -70 °C under sterile conditions after reconstitution.
Buffer
Lyophilized from a 0.2 μm filtered solution in Tris and NaCl.
Purity
>95%, by SDS-PAGE under reducing conditions and visualized by silver stain
Reconstitution Instructions
Reconstitute at 100 μg/mL in sterile 25 mM Tris and 100 mM NaCl, pH 7.5.
Assay Procedure
Activation Buffer: 50 mM Tris, 5 mM DTT, pH 7.0
Assay Buffer: 50 mM Tris, pH 7.0
Recombinant Human Cystatin B (rhCystatin B) (Catalog # 1408-PI)
Papain (Sigma, Catalog # P4762)
Substrate: N-Carbobenzyloxy-Phe-Arg-7-amido-4-methylcoumarin (Z-FR-AMC) (Catalog # ES009), 10 mM stock in DMSO
F16 Black Maxisorp Plate (Nunc, Catalog # 475515)
Fluorescent Plate Reader (Model: SpectraMax Gemini EM by Molecular Devices) or equivalent
Chill Activation Buffer on ice.
Dilute Papain to 100 μg/mL in Activation Buffer.
Incubate at room temperature for 15 minutes.
Prepare a dilution curve of rhCystatin B (MW: 12,092 Da) in Assay Buffer. Make the following serial dilutions: 4000, 800, 400, 300, 200, 150, 100, 50, 25 and 5 nM.
Dilute activated Papain to 2.4 μg/mL in Assay Buffer.
Mix equal volumes of the rhCystatin B curve dilutions and the diluted active Papain. Include a Substrate Blank (in duplicate) containing Assay Buffer and the diluted active Papain.
Incubate mixtures at room temperature for 15 minutes.
Dilute Substrate to 200 μM in assay Buffer.
Perform a five fold dilution with Assay Buffer to the incubated mixture of rhCystatin B and Papain.
Load 50 μL of diluted incubated mixture into a plate and start the reaction by adding 50 μL of 200 μM substrate.
Read at excitation and emission wavelengths of 380 nm and 460 nm, respectively, for 5 minutes in kinetic mode.
Derive the 50% inhibiting concentration (IC50) value for rhCystatin B by plotting RFU/min (or specific activity) vs. concentration with 4‑PL fitting.
The specific activity for Papain at each point may be determined using the following formula (if needed):
Specific Activity (pmol/min/µg) =
Adjusted Vmax* (RFU/min) x Conversion Factor** (pmol/RFU)
amount of enzyme (µg)
*Adjusted for Substrate Blank **Derived using calibration standard 7-Amino, 4‑Methyl Coumarin (AMC) (Sigma, Catalog # A-9891).
Per Well:
Papain: .012 μg
Substrate Z-FR-AMC: 100 μM
rhCystatin B curve: 200, 40, 20, 15, 10, 7.5, 5, 2.5, 1.25, and 0.25 nM
Notes
This product is produced by and ships from R&D Systems, Inc., a Bio-Techne brand.
Alternate Names for Recombinant Human Cystatin B Protein, CF
CPI-B
CST6cystatin B (liver thiol proteinase inhibitor)10STFBcystatin-B
CSTB
cystatin B (stefin B)
Cystatin B
EPM1
Liver thiol proteinase inhibitor
PME
Stefin B
stefin-B
Background
Cystatin B, also called stefin B or liver thiol proteinase inhibitor, is a member of family 1 of the cystatin superfamily (1). Like Cystatin A, it is an intracellular inhibitor regulating the activities of cysteine proteases of the papain family such as cathepsins B, H and L (2). Mutations in the Cystatin B gene is the cause of progressive myoclonus epilepsy (EPM1) (3). Because of its expression patterns, Cystatin B can be used as a marker for certain cancers, such as glioblastoma tumors (4). It readily forms amyloid fibrils in vitro (5). The human Cystatin B consists of 98 amino acid residues (3).
Abrahamson, M. (1994) Methods Enzymol. 244:685.
Pol, E. and I. Bjork (1999) Biochemistry 38:10519.
Pennacchio, L.A. et al. (1996) Science 271:1731.
Zhang, R. et al. (2003) Glia 42:194.
Zerovnik, E. et al. (2002) Biochim. Biophys. Acta 1594:1.
Bioinformatics Tool for Cystatin B/Stefin B (1408-PI)
Discover related pathways, diseases and genes to Cystatin B/Stefin B (1408-PI). Need help?
Read the Bioinformatics Tool Guide for instructions on using this tool.
Diseases for Cystatin B/Stefin B (1408-PI)
Discover more about diseases related to Cystatin B/Stefin B (1408-PI).
The concentration calculator allows you to quickly calculate the volume, mass or concentration of your vial. Simply enter your mass, volume, or concentration values for your reagent and the calculator will determine the rest.
=
÷
Review this Product
Be the first to review our Recombinant Human Cystatin B Protein, CF and receive a gift card or discount.